已收盤 08-29 16:00:00 美东时间
+0.110
+0.28%
今日重点评级关注:Brookline Capital:上调Intensity Therapeutics评级至"买入",目标价3美元;Chardan Capital:维持Taysha Gene Therapies"买入"评级,目标价从9美元升至10美元
08-13 09:10
Wedbush analyst Laura Chico maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Outperform and raises the price target from $42 to $43.
08-12 21:27
Xenon ( ($XENE) ) has shared an update. Xenon Pharmaceuticals reported its seco...
08-12 04:43
Xenon Pharmaceuticals (NASDAQ:XENE) reported quarterly earnings of $1.07 per share which beat the analyst consensus estimate of $(0.99) by 207.65 percent. This is a 242.67 percent increase over losses of $(0.75) per
08-12 04:02
Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to rep...
08-11 16:32
Xenon Pharmaceuticals (NASDAQ:XENE) is gearing up to announce its quarterly ear...
08-08 22:07
Xenon Pharmaceuticals Inc. will release its second quarter 2025 financial results and provide a business update after U.S. markets close on Monday, August 11, 2025. A conference call and webcast will follow at 4:30 pm Eastern Time (1:30 pm Pacific Time). Participants can dial in at (800) 715-9871 (toll-free) or (646) 307-1963 (international), using conference ID 4102397. A webcast will also be available on Xenon’s Investors website for replay. Xe...
08-04 12:01
An announcement from Xenon ( ($XENE) ) is now available. Xenon Pharmaceuticals ...
08-02 05:42
Xenon ( ($XENE) ) has issued an announcement. On June 30, 2025, Xenon Pharmaceu...
07-04 05:51
Xenon Pharmaceuticals (NASDAQ:XENE) on Friday said the company has been added to the broad-market Russell 3000 and small-cap Russell 2000 Indexes as part of the annual reconstitution, effective at the...
06-28 04:09